Studies - Rocky Mountain Clinical Research

CIP 330

This study is to demonstrate the performance of the disposable sensor of the updated Continuous Glucose Monitoring (CGM) system in pediatric patients.

Enrolling

PTL-904120

This study is to establish performance of the Dexcom Continuous Glucose Monitoring (CGM) System in comparison to a blood glucose comparator method.

Enrolling

Abbott 19183

This is a study evaluating the Abbott Sensor Based B-Ketone Monitoring System.

Enrolling

Eli Lilly ITSW

This is a study of LY900014 in participants with Type 2 Diabetes using Continuous Glucose Monitoring.

Enrolling

SURPASS-6

This trial compares the efficacy and safety of tirzepatide once weekly at either 5 mg, 10 mg, 15 mg dose to 3 times a day Lispro in patients with type 2 diabetes on glargine.

Enrolling

Eli Lilly BDCL

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.

On Hold

The Sustain Switch trial compares the effect and safety of 2 different dose schedules for semaglutide (study medicine) in people with type 2 diabetes previously treated with a diabetes medicine similar to semaglutide.

Enrolling

Type 1 Diabetes BDCP Clinical Study

The BDCP clinical study is for type 1 diabetes patients, 18 years or older, to evaluate the safety of LY3209590 in patients being treated with multiple daily injection therapy.

Enrolling

Sunrise

The SUNRISE study is a prospective, multi-center, double-blind, randomized, placebo-controlled trial in subjects aged 18.0 to <41.0 years diagnosed with T1D within 5 years.

Enrolling

AbbVie M16-904

To evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of Leuprolide Acetate 45 mg 6-month depot formulation in children with Central precocious puberty

Enrolling

CIP321

The purpose of the 321 trial is to evaluate the safety of the Advanced Hybrid Closed Loop system (AHCL) in pediatric type 1 diabetes subjects age 7 – 13 in a home setting. The main objective in conducting this research is to collect data from patients who use the AHCL system at home, at work, […]

Enrolling

Semaglutide

Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes.

Enrolling

Protect – Type 1 Diabetes Study

The Protect study will determine whether teplizumab slows the loss of β cells and preserves β cell function in children and adolescent 8-17 years old who have been diagnosed with T1D in the previous 6 weeks.

Enrolling

Pronto-Peds Insulin Study ITSB

The reason for this study is to compare a ultra-rapid lispro to insulin lispro (Humalog) in children and adolescents with type 1 diabetes (T1D).

Enrolling

AbbVie

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events and Efficacy Measures in Hypogonadal Men

On Hold

RLM-MD Study

A 52-week study that compares the efficacy of Relamorelin with that of placebo in participants with diabetic gastroparesis with respect to the core signs and symptoms of diabetic gastroparesis.

Enrolling